Overview

A Study to Assess 18-Methoxycoronaridine (18-MC HCl) in Healthy Volunteers

Status:
Recruiting
Trial end date:
2022-02-07
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the safety and tolerability of a single day dosing and a separate multiple day dosing of 18-MC HCl administered orally, each part of the study having a different set of healthy male and female volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Mind Medicine, Inc.